Tesaro

Organisation

Trials

  • NCT06964165

    Phase 2, Terminated, 36 people, 9 May 2025

  • NCT04762901

    Collaborator, Phase 1, Withdrawn, 0 people, 21 Feb 2021

  • NCT03981796

    Phase 3, Active, not recruiting, 785 people, 11 Jun 2019

  • NCT03960151

    Collaborator, Phase 2, Withdrawn, 0 people, 22 May 2019

  • NCT03574779

    Phase 2, Completed, 77 people, 2 Jul 2018

  • NCT03209401

    Collaborator, Phase 1, Terminated, 23 people, 6 Jul 2017

  • NCT02817633

    Phase 1, Active, not recruiting, 463 people, 29 Jun 2016

  • NCT01500226

    Phase 3, Completed, 1,369 people, 28 Dec 2011

  • NCT01500213

    Phase 3, Completed, 555 people, 28 Dec 2011

  • NCT01499849

    Phase 3, Completed, 532 people, 26 Dec 2011

  • NCT01110603

    Phase 1, Terminated, 12 people, 26 Apr 2010

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov